Business · 24/07/2026
FDA Classifies Diabetes Digital Behavioral Therapeutic Device into Class II with Special Controls
The FDA has classified the diabetes digital behavioral therapeutic device into Class II, a category that requires special controls to ensure safety and effectiveness, aiming to enhance patients' access to innovative devices while reducing regulatory burdens.
Original source language: Federal Register — Health and Human ServicesOpen original release →